title: The Dexamethasone Intravitreal Implant for Noninfectious Uveitis: Practice Patterns Among Uveitis Specialists.
abstract: OBJECTIVE
  To describe the practice patterns and perceptions of uveitis specialists regarding the use of the intravitreal dexamethasone (DEX) implant for the treatment of noninfectious uveitis.
  
  
  METHODS
  We invited uveitis specialists to participate in an anonymous online survey.
  
  
  RESULTS
  Among the 45 respondents, 76.5% identified uveitic macular edema as the most common clinical finding for which they use the DEX implant. The most common contraindications to DEX implantation were aphakia and glaucoma requiring >2 medications. Nearly two-thirds (64.3%) felt that the advent of the DEX implant did not change the frequency with which they used the fluocinolone acetonide (FA) implant, and about one-third (32.3%) preferred to use at least one DEX implant, before committing a patient to an FA implant.
  
  
  CONCLUSIONS
  Uveitis physicians use the DEX implant for a wide range of clinical findings and uveitic diagnoses. There was no clear consensus on preferences regarding the use of DEX versus FA implants.
authors.affiliation: a Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , Maryland , USA and.
authors.forename: Bryn M
authors.initials: BM
authors.lastname: Burkholder
authors.affiliation: a Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , Maryland , USA and.
authors.forename: Ahmadreza
authors.initials: A
authors.lastname: Moradi
authors.affiliation: a Wilmer Eye Institute, Johns Hopkins University School of Medicine , Baltimore , Maryland , USA and.
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Thorne
authors.affiliation: b Wills Eye Hospital , Philadelphia , Pennsylvania , USA.
authors.forename: James P
authors.initials: JP
authors.lastname: Dunn
mesh_terms: D002983:Clinical Competence; D003907:Dexamethasone / Q000008:administration & dosage*; D004343:Drug Implants; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D009885:Ophthalmology; D010820:Physicians / Q000592:standards*; D013038:Specialization; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014605:Uveitis / Q000188:drug therapy*; D000078329:Workforce
chemical_list: D004343:Drug Implants; D005938:Glucocorticoids; D003907:Dexamethasone
keywords: Dexamethasone; fluocinolone; intravitreal implant; uveitis